Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive
Initial data from clinical trials testing whether patients with severe coronavirus illness can be helped by a rheumatoid arthritis drug sold by Regeneron Pharmaceuticals Inc and Sanofi SA may come as early as next week, Regeneron's chief scientific officer told Reuters.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Clinical Trials | Coronavirus | COVID-19 | Health | Rheumatoid Arthritis | Rheumatology